Oral Contraceptives in the Metabolic Syndrome

Trial Profile

Oral Contraceptives in the Metabolic Syndrome

Phase of Trial: Phase IV

Latest Information Update: 16 Jul 2018

At a glance

  • Drugs Ethinylestradiol/norgestimate (Primary)
  • Indications Pregnancy
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jun 2018 Status changed from active, no longer recruiting to completed.
    • 12 Mar 2018 Planned End Date changed from 1 Dec 2017 to 1 Apr 2018.
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top